·5 min read·science
Tirzepatide and pancreatitis: what the data actually shows after 8 years of GLP-1s
The pancreatitis warning on GLP-1s has been around since the early days of the class. The accumulated evidence after 8 years of widespread use is more reassuring than the warning suggests, but the patient-level decision still has nuance.